Animal & Plant Derived Vaccines

It has been about 30 years since the first plant engineering technology was established. Although the concept of plant-based pharmaceuticals or vaccines motivates us to develop practicable commercial products using plant engineering, there are some difficulties in reaching the final goal: to manufacture an approved product. At present, the only plant-made vaccine approved by the United States Department of Agriculture is a Newcastle disease vaccine for poultry that is produced in suspension-cultured tobacco cells. The progress toward commercialization of plant-based vaccines takes much effort and time, but several candidate vaccines for use in humans and animals are in clinical trials. This review discusses plant engineering technologies and regulations relevant to the development of plant-based vaccines and provides an overview of human and animal vaccines currently under clinical trials.

Related: Vaccines Conferences | World Vaccine Congress | Immunology Conferences | Vaccines Conferences 2019 | Immunization Conferences 2019 | HIV Vaccines Conferences | Vaccines Relative Conferences

  • Bovine and porcine products
  • Chicken embryos and embryonated eggs
  • Plants as bioreactors
  • Chloroplast-derived protozoan antigens
  • Chloroplast-derived autoantigens

Related Conference of Animal & Plant Derived Vaccines

December 06-07, 2018

International Congress on Vaccines & Immunology

Amsterdam, Netherlands
March 18-19, 2019

33rdAnnual Vaccines & Vaccination Congress

New York, USA
March 18-19, 2019

35th World Vaccines & Immunization Congress

Novotel Brisbane, Australia
March 21-22, 2019

32nd International Conference on Vaccines and Immunization

Hotel Holiday Inn, Aurelia Rome, Italy
August 12-13, 2019

34th World Congress on Vaccines and Immunization

Auckland,Newzealand

Animal & Plant Derived Vaccines Conference Speakers

Recommended Sessions

Related Journals

Are you interested in